Christopher James Waddick

Cardiol Therapeutics Inc.

Insider activity · 24 months1 buy0 salesCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 1 buy · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Company

▲ Purchases (2 ops.)

€52k

▼ Sales (0 ops.)

—

Latest filing published 17 Dec 2024 for Cardiol Therapeutics Inc., €33k.

Filing timeline

BuySale

Christopher James Waddick

Insider track record

Disclosed buys

Disclosed sells

Signal history

No signal scores available.

Christopher James Waddick: trading record in brief

Christopher James Waddick appears in our data through filings on Cardiol Therapeutics Inc. shares, published by SEDI. In total, 2 filings cover trades dated from 15 October 2019 to 16 December 2024.

No open-market sale appears; the market trades are 2 purchases worth €52k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. 2024 to date brings 1 purchase and no sales.

Most recently, on 17 December 2024, the filings show an open-market purchase worth €33k in Cardiol Therapeutics Inc. Source: insider filings from SEDI. Past trades are no guide to future returns.

Companies and markets linked to Christopher James Waddick

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Cardiol Therapeutics Inc. (CA)

Declarations2 total

▲

Christopher James Waddick

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives16 Dec 2024Cardiol Therapeutics Inc.

49,702 CAD0SEDI

25,900 shares@ CA$1.919Common Shares (Class A)TSXSEDI:4419261

Canonical exit: 16 Mar 2025 (T+90)

▲

Christopher James Waddick

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives15 Oct 2019Cardiol Therapeutics Inc.

27,200 CAD19SEDI

10,000 shares@ CA$2.72100.0% of flowCommon Shares (Class A)TSXSEDI:3439326

Canonical exit: 13 Jan 2020 (T+90)

2 of 2 declarations

Christopher James Waddick: trading record in brief

Christopher James Waddick appears in our data through filings on Cardiol Therapeutics Inc. shares, published by SEDI. In total, 2 filings cover trades dated from 15 October 2019 to 16 December 2024.

Most recently, on 17 December 2024, the filings show an open-market purchase worth €33k in Cardiol Therapeutics Inc. Source: insider filings from SEDI. Past trades are no guide to future returns.

Christopher James Waddick

Insider track record

Christopher James Waddick: trading record in brief

Companies and markets linked to Christopher James Waddick

Related entities

Christopher James Waddick

Insider track record

Christopher James Waddick: trading record in brief

Companies and markets linked to Christopher James Waddick

Related entities